Skip to main content
Erschienen in: International Journal of Public Health 3/2017

28.06.2016 | Original Article

Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results

verfasst von: Abdullah Gandomkar, Hossein Poustchi, Maryam Moini, Mohsen Moghadami, Hadi Imanieh, Mohammad Reza Fattahi, Seyyed Mohammad Taghi Ayatollahi, Mohammad Mahdi Sagheb, Amir Anushiravani, Roozbeh Mortazavi, Sadaf Ghajarieh Sepanlou, Reza Malekzadeh

Erschienen in: International Journal of Public Health | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The pars cohort study (PCS) is a 10-year cohort study aiming to investigate the burden and the major risk factors of non-communicable diseases, and to establish a setting to launch interventions for prevention of these diseases and controlling their risk factors.

Methods

All inhabitants of Valashahr district in South of Iran, aged 40–75 years, were invited to undergo interviews and physical examination, and to provide biological samples. A total of 9264 invitees accepted to participate in the study (95 % participation rate) and were recruited from 2012 to 2014. Active follow-up was also carried out after 12 months.

Results

About 46 % of participants were male and 54 % were female. About 14.0 % of the participants were current smokers and 8.4 % were ever opium users. The prevalence of overweight and obesity were 37.3 and 18.2 %, respectively. The prevalence of hypertension was 26.9 %. A total of 49 participants died during a median follow-up of one year.

Conclusions

PCS with its large scale and wealth of socio-economic and medical data can be a unique platform for studying the etiology of non-communicable diseases and effective interventions in Iran.
Literatur
Zurück zum Zitat Abnet CC, Saadatian-Elahi M, Pourshams A et al (2004) Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 13(6):1068–1070 Abnet CC, Saadatian-Elahi M, Pourshams A et al (2004) Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 13(6):1068–1070
Zurück zum Zitat Azizi F, Rahmani M, Emami H et al (2000) Tehran lipid and glucose study: rationale and design. CVD Prev 3(3):242–247 Azizi F, Rahmani M, Emami H et al (2000) Tehran lipid and glucose study: rationale and design. CVD Prev 3(3):242–247
Zurück zum Zitat Etemadi A, Islami F, Phillips DH et al (2013) Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype. Int J Cancer J Int du Cancer 132(12):2738–2747. doi:10.1002/ijc.27953 CrossRef Etemadi A, Islami F, Phillips DH et al (2013) Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype. Int J Cancer J Int du Cancer 132(12):2738–2747. doi:10.​1002/​ijc.​27953 CrossRef
Zurück zum Zitat Etemadi A, Abnet CC, Kamangar F et al (2014) Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol 29(2):95–109. doi:10.1007/s10654-014-9883-6 CrossRefPubMed Etemadi A, Abnet CC, Kamangar F et al (2014) Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol 29(2):95–109. doi:10.​1007/​s10654-014-9883-6 CrossRefPubMed
Zurück zum Zitat Global Burden of Disease (GBD) Collaborators (2015a) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–71 doi:10.1016/s0140-6736(14)61682-2 Global Burden of Disease (GBD) Collaborators (2015a) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–71 doi:10.​1016/​s0140-6736(14)61682-2
Zurück zum Zitat Global Burden of Disease (GBD) Collaborators (2015b) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.1016/s0140-6736(15)60692-4 CrossRef Global Burden of Disease (GBD) Collaborators (2015b) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.​1016/​s0140-6736(15)60692-4 CrossRef
Zurück zum Zitat Islami F, Pourshams A, Vedanthan R et al (2013) Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart (British Cardiac Society) 99(4):272–278. doi:10.1136/heartjnl-2012-302861 Islami F, Pourshams A, Vedanthan R et al (2013) Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart (British Cardiac Society) 99(4):272–278. doi:10.​1136/​heartjnl-2012-302861
Zurück zum Zitat Kamangar F, Malekzadeh R, Dawsey SM, Saidi F (2007) Esophageal cancer in Northeastern Iran: a review. Arch Iran Med 10(1):70–82PubMed Kamangar F, Malekzadeh R, Dawsey SM, Saidi F (2007) Esophageal cancer in Northeastern Iran: a review. Arch Iran Med 10(1):70–82PubMed
Zurück zum Zitat Khademi H, Malekzadeh R, Pourshams A et al (2012) Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (Clinical Research ed) 344:e2502. doi:10.1136/bmj.e2502 Khademi H, Malekzadeh R, Pourshams A et al (2012) Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (Clinical Research ed) 344:e2502. doi:10.​1136/​bmj.​e2502
Zurück zum Zitat Majed M, Moradmand Badie S (2011) A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors. Arch Iran Med 14(1):78–80PubMed Majed M, Moradmand Badie S (2011) A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors. Arch Iran Med 14(1):78–80PubMed
Zurück zum Zitat Malekshah AF, Kimiagar M, Saadatian-Elahi M et al (2006) Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 60(8):971–977. doi:10.1038/sj.ejcn.1602407 CrossRefPubMed Malekshah AF, Kimiagar M, Saadatian-Elahi M et al (2006) Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 60(8):971–977. doi:10.​1038/​sj.​ejcn.​1602407 CrossRefPubMed
Zurück zum Zitat Murray CJ, Barber RM, Foreman KJ et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. doi:10.1016/s0140-6736(15)61340-x Murray CJ, Barber RM, Foreman KJ et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. doi:10.​1016/​s0140-6736(15)61340-x
Zurück zum Zitat Najafi I, Shakeri R, Islami F et al (2012) Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. Arch Iran Med 15(2):70–75PubMed Najafi I, Shakeri R, Islami F et al (2012) Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. Arch Iran Med 15(2):70–75PubMed
Zurück zum Zitat Najafipour H, Mirzazadeh A, Haghdoost A et al (2012) Coronary artery disease risk factors in an Urban and Peri-urban setting, Kerman, Southeastern Iran (KERCADR Study): methodology and preliminary report. Iran J Publ Health 41(9):86–92 Najafipour H, Mirzazadeh A, Haghdoost A et al (2012) Coronary artery disease risk factors in an Urban and Peri-urban setting, Kerman, Southeastern Iran (KERCADR Study): methodology and preliminary report. Iran J Publ Health 41(9):86–92
Zurück zum Zitat Ostovaneh MR, Poustchi H, Hemming K et al (2014) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. Eur J Prev Cardiol. doi:10.1177/2047487314550803 PubMed Ostovaneh MR, Poustchi H, Hemming K et al (2014) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. Eur J Prev Cardiol. doi:10.​1177/​2047487314550803​ PubMed
Zurück zum Zitat Pourshams A, Khademi H, Malekshah AF et al (2010) Cohort profile: the golestan cohort study—a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 39(1):52–59. doi:10.1093/ije/dyp161 CrossRefPubMed Pourshams A, Khademi H, Malekshah AF et al (2010) Cohort profile: the golestan cohort study—a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 39(1):52–59. doi:10.​1093/​ije/​dyp161 CrossRefPubMed
Zurück zum Zitat Rabiei K, Kelishadi R, Sarrafzadegan N et al (2009) Process evaluation of a community-based program for prevention and control of non-communicable disease in a developing country: the Isfahan Healthy Heart Program, Iran. BMC Publ health 9:57. doi:10.1186/1471-2458-9-57 CrossRef Rabiei K, Kelishadi R, Sarrafzadegan N et al (2009) Process evaluation of a community-based program for prevention and control of non-communicable disease in a developing country: the Isfahan Healthy Heart Program, Iran. BMC Publ health 9:57. doi:10.​1186/​1471-2458-9-57 CrossRef
Zurück zum Zitat Sepanlou SG, Sharafkhah M, Poustchi MM et al (2015b) Hypertension and mortality in the Golestan Cohort Study: a prospective study of 50 000 adults in Iran. J Hum Hypertens. doi:10.1038/jhh.2015.57 PubMed Sepanlou SG, Sharafkhah M, Poustchi MM et al (2015b) Hypertension and mortality in the Golestan Cohort Study: a prospective study of 50 000 adults in Iran. J Hum Hypertens. doi:10.​1038/​jhh.​2015.​57 PubMed
Zurück zum Zitat The WHO STEPwise approach to non-communicable disease risk factor surveillance (STEPS) (2004). World Health Organization, Geneva. Available at: www.who.int/chp/steps [Last accessed 12 April 2016] The WHO STEPwise approach to non-communicable disease risk factor surveillance (STEPS) (2004). World Health Organization, Geneva. Available at: www.​who.​int/​chp/​steps [Last accessed 12 April 2016]
Zurück zum Zitat Zamani N, Hajifaraji M, Fazel-tabar Malekshah A et al (2013) A case-control study of the relationship between gastric cancer and meat consumption in Iran. Arch Iran Med 16(6):324–329PubMed Zamani N, Hajifaraji M, Fazel-tabar Malekshah A et al (2013) A case-control study of the relationship between gastric cancer and meat consumption in Iran. Arch Iran Med 16(6):324–329PubMed
Metadaten
Titel
Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results
verfasst von
Abdullah Gandomkar
Hossein Poustchi
Maryam Moini
Mohsen Moghadami
Hadi Imanieh
Mohammad Reza Fattahi
Seyyed Mohammad Taghi Ayatollahi
Mohammad Mahdi Sagheb
Amir Anushiravani
Roozbeh Mortazavi
Sadaf Ghajarieh Sepanlou
Reza Malekzadeh
Publikationsdatum
28.06.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Public Health / Ausgabe 3/2017
Print ISSN: 1661-8556
Elektronische ISSN: 1661-8564
DOI
https://doi.org/10.1007/s00038-016-0848-2

Weitere Artikel der Ausgabe 3/2017

International Journal of Public Health 3/2017 Zur Ausgabe